163 related articles for article (PubMed ID: 31767150)
1. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
[TBL] [Abstract][Full Text] [Related]
3. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
[TBL] [Abstract][Full Text] [Related]
5. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
Sanduja S; Kaza V; Dixon DA
Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Coelho MA; de Carné Trécesson S; Rana S; Zecchin D; Moore C; Molina-Arcas M; East P; Spencer-Dene B; Nye E; Barnouin K; Snijders AP; Lai WS; Blackshear PJ; Downward J
Immunity; 2017 Dec; 47(6):1083-1099.e6. PubMed ID: 29246442
[TBL] [Abstract][Full Text] [Related]
8. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
[TBL] [Abstract][Full Text] [Related]
9. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
[TBL] [Abstract][Full Text] [Related]
11. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.
Qian X; Ning H; Zhang J; Hoft DF; Stumpo DJ; Blackshear PJ; Liu J
J Immunol; 2011 Jun; 186(11):6454-64. PubMed ID: 21515794
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
Zhao W; Liu M; D'Silva NJ; Kirkwood KL
J Interferon Cytokine Res; 2011 Aug; 31(8):629-37. PubMed ID: 21457063
[TBL] [Abstract][Full Text] [Related]
15. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
[TBL] [Abstract][Full Text] [Related]
16. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1.
Lee HH; Lee SR; Leem SH
J Microbiol Biotechnol; 2014 Feb; 24(2):287-94. PubMed ID: 24150491
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
18. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.
Chen F; Shyu AB; Shneider BL
Hepatology; 2011 Oct; 54(4):1371-8. PubMed ID: 21688286
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
Ogilvie RL; Abelson M; Hau HH; Vlasova I; Blackshear PJ; Bohjanen PR
J Immunol; 2005 Jan; 174(2):953-61. PubMed ID: 15634918
[TBL] [Abstract][Full Text] [Related]
20. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
